
- Volume 0 0
GENETICS 101: COMMON INHERITED CLOTTING DISORDERS
Inherited thrombophilia occurs whenan inherited DNA mutation results in thebody producing too much or too little ofa clotting protein or if the clotting proteindoes not function correctly. There are anumber of hereditary clotting disorders,but the 2 most common are factor VLeiden and prothrombin G20210A mutations.
Factor V Leiden causes factor V proteinto be abnormally shaped and prevents itfrom being broken down by proteins Cand S. About 5% of Caucasians carry thismutation, while only 1% to 2% of AfricanAmericans, Hispanic Americans, andNative Americans are affected. A prothrombingene mutation causes theaffected individual to produce too muchof the prothrombin protein, which increasesthe tendency to clot. Prothrombingene mutations occur in 2% to 4% ofCaucasians and about 0.4% of AfricanAmericans. It is rarer in other groups.
A genetic predisposition to clottingdoes not mean that the patient will definitelyhave a blood clot, but knowledgeof the problem may be useful for a numberof reasons. For example, women whoare affected may need to avoid estrogencontainingoral contraceptives and mayrequire use of anticoagulants duringpregnancy, since clotting risk increasesin pregnancy. Patients who have knownthrombophilia should be counseledregarding the signs and symptoms ofthromboembolism and be advised totake these symptoms seriously.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Carein High Point, NC.
Articles in this issue
over 18 years ago
Maniaover 18 years ago
Smoking Cessationover 18 years ago
New Drugs of 2006over 18 years ago
compounding HOTLINEover 18 years ago
Prevention and Treatment of Hyperglycemia in Hospitalized Patientsover 18 years ago
Reconsidering the Ban on Ephedra Productsover 18 years ago
Worldwide Prescription Drug Abuseover 18 years ago
RESPy AWARD: Dia Makes a Difference in Pharmacyover 18 years ago
E-prescribing Can Make a Difference for Medicare Part Dover 18 years ago
ncpa SPEAKS OUT: Medicaid Actions, Pharmacy ReactionsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.